Robert J. van Soest

1.2k total citations
25 papers, 928 citations indexed

About

Robert J. van Soest is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Robert J. van Soest has authored 25 papers receiving a total of 928 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Pulmonary and Respiratory Medicine, 12 papers in Oncology and 9 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Robert J. van Soest's work include Prostate Cancer Treatment and Research (23 papers), Radiopharmaceutical Chemistry and Applications (9 papers) and Prostate Cancer Diagnosis and Treatment (7 papers). Robert J. van Soest is often cited by papers focused on Prostate Cancer Treatment and Research (23 papers), Radiopharmaceutical Chemistry and Applications (9 papers) and Prostate Cancer Diagnosis and Treatment (7 papers). Robert J. van Soest collaborates with scholars based in Netherlands, United States and Canada. Robert J. van Soest's co-authors include Ronald de Wit, Ron H.J. Mathijssen, Wytske M. van Weerden, Ellen S. de Morrée, Erik A.C. Wiemer, Martin E. van Royen, Wilma J. Teubel, Paul Hamberg, Ian F. Tannock and Mario A. Eisenberger and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer Research.

In The Last Decade

Robert J. van Soest

25 papers receiving 918 citations

Peers

Robert J. van Soest

PRM

ONCOL

RNMI

Andrea Zivi United Kingdom

Mari Nakazawa United States

Eren Demirhan United States

Julia Shelkey United States

Fabian Zohren United States

Sinja Taavitsainen Finland

Daniel Khalaf Canada

Giri Sulur United States

Joanna Vergidis Canada

S. Polyakov Belarus

Andrea Zivi United Kingdom

Robert J. van Soest

643 ×0.8

PRM

283 ×0.8

185 ×0.6

ONCOL

284 ×1.1

RNMI

346 ×1.6

Citations per year, relative to Robert J. van Soest Robert J. van Soest (= 1×) peers Andrea Zivi

Countries citing papers authored by Robert J. van Soest

Since Specialization

Citations

This map shows the geographic impact of Robert J. van Soest's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert J. van Soest with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert J. van Soest more than expected).

Fields of papers citing papers by Robert J. van Soest

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert J. van Soest. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert J. van Soest. The network helps show where Robert J. van Soest may publish in the future.

Co-authorship network of co-authors of Robert J. van Soest

This figure shows the co-authorship network connecting the top 25 collaborators of Robert J. van Soest. A scholar is included among the top collaborators of Robert J. van Soest based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert J. van Soest. Robert J. van Soest is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Soeterik, Timo, et al.. (2022). A side-specific nomogram for extraprostatic extension may reduce the positive surgical margin rate in radical prostatectomy. World Journal of Urology. 40(12). 2919–2924. 7 indexed citations

Koolen, Stijn L.W., et al.. (2021). Cross-resistance and drug sequence in prostate cancer. Drug Resistance Updates. 56. 100761–100761. 54 indexed citations

Hussaarts, Koen G. A. M., Esther Oomen‐de Hoop, Peter de Bruijn, et al.. (2019). Effects of prednisone on docetaxel pharmacokinetics in men with metastatic prostate cancer: A randomized drug–drug interaction study. British Journal of Clinical Pharmacology. 85(5). 986–992. 8 indexed citations

Sieuwerts, Anieta M., Esther Oomen‐de Hoop, Bianca Mostert, et al.. (2019). Associations between AR-V7 status in circulating tumour cells, circulating tumour cell count and survival in men with metastatic castration-resistant prostate cancer. European Journal of Cancer. 121. 48–54. 23 indexed citations

Wit, Ronald de, et al.. (2019). Novel treatment options in the management of metastatic castration-naïve prostate cancer; which treatment modality to choose?. Annals of Oncology. 30(10). 1591–1600. 14 indexed citations

Kumagai, Jinpei, Martin E. van Royen, Wilma J. Teubel, et al.. (2019). A bypass mechanism of abiraterone‐resistant prostate cancer: Accumulating CYP17A1 substrates activate androgen receptor signaling. The Prostate. 79(9). 937–948. 17 indexed citations

Tombal, Bertrand & Robert J. van Soest. (2017). STAMPEDE, LATITUDE and Fernand Labrie's legacy. Nature Reviews Urology. 14(10). 588–590. 5 indexed citations

Nieuweboer, Annemieke J.M., Anne‐Joy M. de Graan, Paul Hamberg, et al.. (2016). Effects of Budesonide on Cabazitaxel Pharmacokinetics and Cabazitaxel-Induced Diarrhea: A Randomized, Open-Label Multicenter Phase II Study. Clinical Cancer Research. 23(7). 1679–1683. 12 indexed citations

Morrée, Ellen S. de, René Böttcher, Robert J. van Soest, et al.. (2016). Loss of SLCO1B3 drives taxane resistance in prostate cancer. British Journal of Cancer. 115(6). 674–681. 51 indexed citations

10.

Bins, Sander, Annemieke J.M. Nieuweboer, Anne‐Joy M. de Graan, et al.. (2016). A randomized phase II multicenter trial on the effects of budesonide on cabazitaxel-induced diarrhea: CABARESC.. Journal of Clinical Oncology. 34(15_suppl). 5073–5073. 1 indexed citations

11.

Soest, Robert J. van, Peter de Bruijn, Herman Burger, et al.. (2016). Understanding taxanes in prostate cancer; importance of intratumoral drug accumulation. The Prostate. 76(10). 927–936. 30 indexed citations

12.

Soest, Robert J. van, Annemieke J.M. Nieuweboer, Ellen S. de Morrée, et al.. (2015). The influence of prior novel androgen receptor targeted therapy on the efficacy of cabazitaxel in men with metastatic castration-resistant prostate cancer. European Journal of Cancer. 51(17). 2562–2569. 47 indexed citations

13.

Onstenk, Wendy, Anieta M. Sieuwerts, Jaco Kraan, et al.. (2015). Efficacy of Cabazitaxel in Castration-resistant Prostate Cancer Is Independent of the Presence of AR-V7 in Circulating Tumor Cells. European Urology. 68(6). 939–945. 195 indexed citations

14.

Soest, Robert J. van, Arnoud J. Templeton, Francisco Vera-Badillo, et al.. (2014). Neutrophil-to-lymphocyte ratio as a prognostic biomarker for men with metastatic castration-resistant prostate cancer receiving first-line chemotherapy: data from two randomized phase III trials. Annals of Oncology. 26(4). 743–749. 112 indexed citations

15.

Soest, Robert J. van, Ellen S. de Morrée, Charlotte F. Kweldam, et al.. (2014). Targeting the Androgen Receptor Confers In Vivo Cross-resistance Between Enzalutamide and Docetaxel, But Not Cabazitaxel, in Castration-resistant Prostate Cancer. European Urology. 67(6). 981–985. 96 indexed citations

16.

Soest, Robert J. van, Ellen S. de Morrée, Liji Shen, et al.. (2013). Initial Biopsy Gleason Score as a Predictive Marker for Survival Benefit in Patients with Castration-resistant Prostate Cancer Treated with Docetaxel: Data from the TAX327 Study. European Urology. 66(2). 330–336. 45 indexed citations

17.

Soest, Robert J. van, Martin E. van Royen, Ellen S. de Morrée, et al.. (2013). Cross-resistance between taxanes and new hormonal agents abiraterone and enzalutamide may affect drug sequence choices in metastatic castration-resistant prostate cancer. European Journal of Cancer. 49(18). 3821–3830. 175 indexed citations

18.

Soest, Robert J. van, Martin E. van Royen, Ellen S. de Morrée, et al.. (2013). Effects on androgen receptor nuclear import by docetaxel, cabazitaxel, abiraterone, and enzalutamide: Potential mechanism for cross-resistance in castration-resistant prostate cancer (CRPC).. Journal of Clinical Oncology. 31(15_suppl). 5064–5064. 4 indexed citations

19.

Soest, Robert J. van, et al.. (2013). The initial biopsy Gleason score as a predictive marker for docetaxel survival benefit in patients with prostate cancer: Data from the TAX 327 study.. Journal of Clinical Oncology. 31(6_suppl). 44–44. 3 indexed citations

20.

Dijk, Johannes van, Manuel Aivado, Michel Delforge, et al.. (2001). Analysis of clonality by HUMARA PCR in high risk MDS patients before and after intensive anti-leukemic treatment. Blood. 98(11). 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact